Skip to content

Effect of Autologous Peripheral Blood Stem Cell Treatment on Articular Cartilage Regeneration

Articular Cartilage Regeneration With Autologous Peripheral Blood Stem Cells Versus Hyaluronic Acid: A Randomized, Controlled Trial

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01076673
Enrollment
50
Registered
2010-02-26
Start date
2009-10-31
Completion date
2012-05-31
Last updated
2015-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Articular Cartilage Disorder of Knee

Brief summary

The purpose of this study was to compare histologic and MRI evaluation of articular cartilage regeneration in patients with chondral lesions treated by arthroscopic subchondral drilling followed by postoperative intra-articular injections of hyaluronic acid (HA) with and without peripheral blood stem cells (PBSC)

Detailed description

The purpose of this study was to compare histologic and magnetic resonance imaging (MRI) evaluation of articular cartilage regeneration in patients with chondral lesions treated by arthroscopic subchondral drilling followed by postoperative intra-articular injections of hyaluronic acid (HA) with and without peripheral blood stem cells (PBSC)

Interventions

BIOLOGICALPeripheral blood stem cells and hyaluronic acid injections

Peripheral blood stem cells and hyaluronic acid injections

DRUGHyaluronic Acid

Hyaluronic acid injections

Sponsors

Ministry of Science, Technology and Innovation (MOSTI) Malaysia
CollaboratorUNKNOWN
Kuala Lumpur Sports Medicine Centre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Patients who have signed informed consent form * Patients with only unilateral isolated or multiple knee articular cartilage lesions demonstrated MRI scanning, with up to one previous operation on that knee * Patients who are either male or female aged between 18 to 50 years old, corresponding to availability of normative International Knee Documentation Committee (IKDC) data. * Female patients of childbearing age must have negative pregnancy tests and are advised to take contraceptive precautions throughout the study.

Exclusion criteria

* Patients with bilateral knee lesions * Patients with the presence of ligamentous injury which would require reconstruction, varus or valgus deformity greater than 10 degrees, previous open total menisectomy requiring osteotomy, and cases that require complex surgery prior to cartilage regeneration * Patients with significant cognitive impairment, non-ambulatory status or lower extremities amputation other than toes, serious illness or medication affecting operative risk or wound healing (e.g. steroid intake, anticoagulation), and poorly controlled diabetes mellitus with a baseline HbA1c more than 8 * Patients with significant peripheral vascular disease as indicated by absent dorsalis pedis or posterior tibial pulses. * Patients who cannot read English will be excluded from the study as they will be unable to complete the study questionnaires in an objective manner * Female patients who are pregnant * Patients with any contradictions to MRI scanning * Patients with body mass index (BMI) of over 35

Design outcomes

Primary

MeasureTime frame
Change in tissue histology after subchondral drilling surgery using serial MRI scanning and cartilage biopsies18 months

Secondary

MeasureTime frame
Improved long term functional outcome of subchondral drilling surgery in the knee joint18 months

Countries

Malaysia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026